Concepedia

Xianglin Chu

XC

Statistics

Publications

3

Citations

55

H-Index

3

Active since

2022

Affiliations

China Pharmaceutical University(Current)

State Key Laboratory of Natural Medicine

Shanghai Institute of Organic Chemistry

University of Chinese Academy of Sciences

Xianglin Chu is an author at China Pharmaceutical University specializing in pharmacology, therapeutic resistance mechanisms, and oncology.

Publications per year

2022–2023

3

Publications

3

Development of highly potent and specific AKR1C3 inhibitors to restore the chemosensitivity of drug-resistant breast cancer

Yang Liu, Yuting Chen, Jiheng Jiang et al. · European Journal of Medicinal Chemistry · 2022 · 22 citations · Full text

, , +14

Discovery of Novel Aldo-Keto Reductase 1C3 Inhibitors as Chemotherapeutic Potentiators for Cancer Drug Resistance

Siyu He, Yang Liu, Xianglin Chu et al. · ACS Medicinal Chemistry Letters · 2022 · 17 citations · Full text

, , +11

Development of Biaryl-Containing Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors for Reversing AKR1C3-Mediated Drug Resistance in Cancer Treatment

Siyu He, Xianglin Chu, Yujia Wu et al. · Journal of Medicinal Chemistry · 2023 · 16 citations · Full text

, , +15

1–3 of 3